Ahmedabad-based Torrent Pharmaceuticals Ltd entered a binding agreement to acquire a manufacturing unit of Hyderabad-based Glochem Industries Ltd. The Visakhapatnam unit, approved by the US Federal Drug Administration (FDA) and European regulatory authorities, is a multi-product facility which can manufacture advance intermediates and active pharmaceutical ingredients (APIs). With the latest acquisition, Torrent Pharma, which currently has five formulation manufacturing units, will have three API units for the regulated markets. The acquisition will help the firm in vertically integrating its abbreviated new drug application (ANDA) filings in the future, it said in a statement.
“Acquisition of this site will further help in backward integration and scale-up of Torrent’s manufacturing capacity to meet the growing demand from the international markets,” Jinesh Shah, executive director (operations) at Torrent Pharma, said in the statement.
The facility located at JNPC Parawada District, Vizag, currently has three blocks for advance Intermediate manufacturing and four blocks for API manufacturing. The facility also has capabilities for on site development, analytical method development, Quality Control laboratory and a Pilot Plant.
